Catalent Inc.. (CTLT) NEW YORK STOCK EXCHANGE INC.

$120.86 -1.61 (-1.31%)

Market Cap: $20.97B

As of 12/06/21 04:03 PM EST. Market closed.

(CTLT)

Catalent Inc.. (CTLT) NEW YORK STOCK EXCHANGE INC.

$120.86 -1.61 (-1.31%)

Market Cap: $20.97B

As of 12/06/21 04:03 PM EST. Market closed.

Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable ... read more

Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$1.03M
CEO Compensation (Total)
$8.51M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
13,900
CEO Compensation (Base)
$1.03M
CEO Compensation (Total)
$8.51M
Address
.
KEY STATS
Open
$122.39
Previous Close
$122.47
Days Range
$120.50 - $129.65
52 week range
$91.87 - $142.64
Volume
1,074,720
Avg. Volume (30 days)
1,088,936
Market Cap
$20.97B
Dividend Yield
0.00%
P/E
38.53
Shares Outstanding
171,188,042
Open
$122.39
Previous Close
$122.47
Days Range
$120.50 - $129.65
52 week range
$91.87 - $142.64
Volume
1,074,720
Avg. Volume (30 days)
1,088,936
Market Cap
$20.97B
Dividend Yield
0.00%
P/E
38.53
Shares Outstanding
171,188,042

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CATALENT INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Zippelius Peter Director Nov 18, 2021 Option Exercise $49.54 7,822,946 387,555,795 7,822,946 Dec 01, 2021, 08:35 PM
Zippelius Peter Director Nov 30, 2021 Sale $129.30 3,000,000 387,900,009 4,822,946 Dec 01, 2021, 08:35 PM
CARROLL J MARTIN Director Nov 29, 2021 Option Exercise $134.12 3,136 420,600 11,663 Dec 01, 2021, 01:41 PM
CARROLL J MARTIN Director Nov 29, 2021 Option Exercise $134.12 3,136 420,600 0 Dec 01, 2021, 01:41 PM
LUCIER GREGORY T Director Nov 23, 2021 Sale $127.35 5,068 645,407 2,400 Nov 24, 2021, 12:40 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Nov 01, 2021 Option Exercise $44.77 7,559 338,421 52,643 Nov 03, 2021, 03:35 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Nov 01, 2021 Sale $140.02 10,672 1,494,293 41,971 Nov 03, 2021, 03:35 PM
Kreuzburg Christa Director Oct 28, 2021 Option Exercise $135.50 638 86,449 9,330 Nov 01, 2021, 08:00 AM
Castellano Thomas P SVP, Chief Financial Officer Oct 20, 2021 Sale $134.00 2,307 309,138 15,398 Oct 21, 2021, 07:16 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Oct 14, 2021 Sale $129.41 1,661 214,950 45,084 Oct 18, 2021, 02:33 PM
Schmidt Kay A SVP, Technical Operations Oct 04, 2021 Sale $131.25 2,191 287,569 13,778 Oct 06, 2021, 05:37 PM
Fasman Steven L SVP & General Counsel Oct 04, 2021 Option Exercise $51.51 17,259 889,050 91,847 Oct 06, 2021, 05:37 PM
Fasman Steven L SVP & General Counsel Oct 04, 2021 Sale $129.05 34,714 4,479,975 71,334 Oct 06, 2021, 05:37 PM
Pravda Ricardo SVP & Chief HR Officer Oct 01, 2021 Option Exercise $63.30 3,818 241,694 16,653 Oct 05, 2021, 06:51 PM
Pravda Ricardo SVP & Chief HR Officer Oct 01, 2021 Sale $132.68 4,906 650,928 11,747 Oct 05, 2021, 06:51 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Oct 01, 2021 Sale $131.66 2,055 270,557 14,357 Oct 05, 2021, 06:51 PM
Chiminski John R Chair & CEO Oct 01, 2021 Option Exercise $39.39 75,838 2,986,973 294,710 Oct 05, 2021, 06:51 PM
Chiminski John R Chair & CEO Oct 01, 2021 Sale $130.90 152,637 19,979,610 290,109 Oct 05, 2021, 06:51 PM
Kreuzburg Christa Director Aug 27, 2021 Option Exercise $129.85 199 25,840 8,566 Aug 31, 2021, 05:28 PM
Castellano Thomas P SVP, Chief Financial Officer Aug 27, 2021 Sale $131.13 2,093 274,458 19,640 Aug 30, 2021, 09:43 PM
Schmidt Kay A SVP, Technical Operations Aug 27, 2021 Sale $131.13 825 108,183 16,731 Aug 30, 2021, 09:43 PM
Hopson Ricky VP, Chief Accounting Officer Aug 27, 2021 Sale $131.13 1,471 192,894 20,758 Aug 30, 2021, 09:42 PM
Pravda Ricardo SVP & Chief HR Officer Aug 27, 2021 Sale $131.13 692 90,742 13,474 Aug 30, 2021, 09:42 PM
Maselli Alessandro President & COO Aug 27, 2021 Sale $131.13 3,743 490,824 29,359 Aug 30, 2021, 09:41 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 27, 2021 Sale $130.78 4,173 545,725 22,062 Aug 30, 2021, 09:41 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Aug 27, 2021 Sale $131.13 1,698 222,661 16,127 Aug 30, 2021, 09:40 PM
Gennadios Aristippos President Softgel & Oral Tech Aug 27, 2021 Sale $131.13 2,262 296,619 59,572 Aug 30, 2021, 09:40 PM
Fasman Steven L SVP & General Counsel Aug 27, 2021 Sale $131.13 6,111 801,344 80,238 Aug 30, 2021, 09:39 PM
Chiminski John R Chair & CEO Aug 27, 2021 Sale $131.06 44,488 5,830,710 270,760 Aug 30, 2021, 09:39 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Aug 27, 2021 Sale $131.13 452 59,271 47,162 Aug 30, 2021, 09:38 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Jan 13, 2020 Sale $58.00 1,680 97,440 11,647 Aug 23, 2021, 06:35 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Dec 20, 2019 Sale $56.00 2,406 134,736 13,327 Aug 23, 2021, 06:35 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Dec 19, 2019 Sale $54.00 1,846 99,684 15,733 Aug 23, 2021, 06:35 PM
Castellano Thomas P SVP, Chief Financial Officer Jul 26, 2021 Sale $113.05 555 62,743 14,463 Jul 28, 2021, 04:29 PM
Schmidt Kay A SVP, Technical Operations Jul 26, 2021 Sale $113.05 547 61,838 13,319 Jul 28, 2021, 04:29 PM
Hopson Ricky VP, Chief Accounting Officer Jul 26, 2021 Sale $113.05 360 40,698 16,056 Jul 28, 2021, 04:28 PM
Pravda Ricardo SVP & Chief HR Officer Jul 26, 2021 Sale $113.05 458 51,777 10,612 Jul 28, 2021, 04:28 PM
Maselli Alessandro President & COO Jul 26, 2021 Sale $113.05 993 112,259 18,625 Jul 28, 2021, 04:28 PM
Gunther Scott SVP, Quality & Reg. Affairs Jul 26, 2021 Sale $113.04 1,079 121,967 15,900 Jul 28, 2021, 04:27 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Jul 26, 2021 Sale $113.05 451 50,986 16,605 Jul 28, 2021, 04:27 PM
Gennadios Aristippos President Softgel & Oral Tech Jul 26, 2021 Sale $113.05 465 52,568 50,850 Jul 28, 2021, 04:27 PM
Fasman Steven L SVP & General Counsel Jul 26, 2021 Sale $113.05 1,549 175,114 67,363 Jul 28, 2021, 04:26 PM
Chiminski John R Chair & CEO Jul 26, 2021 Sale $113.05 11,137 1,259,038 152,481 Jul 28, 2021, 04:25 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Jul 26, 2021 Sale $113.05 120 13,566 38,482 Jul 28, 2021, 04:25 PM
Fasman Steven L SVP & General Counsel Jul 15, 2021 Sale $109.86 4,500 494,353 70,099 Jul 16, 2021, 01:06 PM
Pravda Ricardo SVP & Chief HR Officer Jun 23, 2021 Sale $110.58 2,800 309,624 11,070 Jun 24, 2021, 06:10 PM
Schmidt Kay A SVP, Technical Operations Mar 22, 2021 Sale $105.77 1,400 148,078 13,866 Mar 23, 2021, 07:27 PM
Fasman Steven L SVP & General Counsel Mar 18, 2021 Option Exercise $38.78 21,647 839,445 94,954 Mar 22, 2021, 02:20 PM
Fasman Steven L SVP & General Counsel Mar 18, 2021 Sale $104.53 21,647 2,262,770 82,039 Mar 22, 2021, 02:20 PM
Chiminski John R Chair & CEO Mar 18, 2021 Option Exercise $36.02 42,220 1,520,764 205,838 Mar 22, 2021, 02:19 PM
Chiminski John R Chair & CEO Mar 19, 2021 Option Exercise $42.06 183,024 7,698,674 346,642 Mar 22, 2021, 02:19 PM
Chiminski John R Chair & CEO Mar 18, 2021 Sale $105.16 42,220 4,439,855 163,618 Mar 22, 2021, 02:19 PM
Chiminski John R Chair & CEO Mar 19, 2021 Sale $106.01 183,024 19,402,784 276,059 Mar 22, 2021, 02:19 PM
Joseph Wetteny SVP & Chief Financial Officer Feb 16, 2021 Option Exercise $52.56 5,000 262,799 54,823 Feb 18, 2021, 09:56 AM
Joseph Wetteny SVP & Chief Financial Officer Feb 16, 2021 Sale $124.54 5,000 622,685 53,024 Feb 18, 2021, 09:56 AM
Joseph Wetteny SVP & Chief Financial Officer Feb 08, 2021 Sale $113.73 4,604 523,613 49,823 Feb 10, 2021, 09:05 AM
Whitlow Ricci S President, CSS Jan 21, 2021 Sale $118.85 692 82,244 2,576 Jan 25, 2021, 07:17 AM
Flynn Karen Pres. Biologics & CCO Jan 11, 2021 Sale $112.30 2,478 278,279 35,644 Jan 11, 2021, 07:12 PM
Gunther Scott SVP, Quality & Reg. Affairs Jan 06, 2021 Sale $104.78 61 6,392 16,509 Jan 07, 2021, 07:04 AM
Whitlow Ricci S President, CSS Jan 04, 2021 Sale $104.42 83 8,667 3,268 Jan 05, 2021, 09:47 PM
Schmidt Kay A SVP, Technical Operations Jan 04, 2021 Sale $104.42 73 7,623 15,266 Jan 05, 2021, 09:47 PM
Pravda Ricardo SVP & Chief HR Officer Jan 04, 2021 Sale $104.42 78 8,145 13,870 Jan 05, 2021, 09:46 PM
Maselli Alessandro President & COO Jan 04, 2021 Sale $104.42 148 15,454 19,618 Jan 05, 2021, 09:46 PM
Joseph Wetteny SVP & Chief Financial Officer Jan 04, 2021 Sale $104.42 172 17,960 54,427 Jan 05, 2021, 09:46 PM
Gunther Scott SVP, Quality & Reg. Affairs Jan 04, 2021 Sale $104.42 120 12,530 16,570 Jan 05, 2021, 09:45 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Jan 04, 2021 Sale $104.42 126 13,157 17,076 Jan 05, 2021, 09:45 PM
Gennadios Aristippos President Softgel & Oral Tech Jan 04, 2021 Sale $104.42 110 11,486 51,315 Jan 05, 2021, 09:45 PM
Flynn Karen Pres. Biologics & CCO Jan 04, 2021 Sale $104.42 99 10,338 37,022 Jan 05, 2021, 09:44 PM
Fasman Steven L SVP & General Counsel Jan 04, 2021 Sale $104.42 189 19,735 73,307 Jan 05, 2021, 09:44 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Jan 04, 2021 Sale $104.42 16 1,671 38,602 Jan 05, 2021, 09:44 PM
Gennadios Aristippos President Softgel & Oral Tech Dec 21, 2020 Option Exercise $32.68 13,662 446,526 61,151 Dec 23, 2020, 07:19 AM
Gennadios Aristippos President Softgel & Oral Tech Dec 21, 2020 Sale $102.84 13,662 1,405,044 51,425 Dec 23, 2020, 07:19 AM
Zippelius Peter Director Nov 23, 2020 Option Exercise $49.54 5,392,280 267,138,411 5,392,280 Nov 25, 2020, 05:53 PM
Zippelius Peter Director Nov 23, 2020 Sale $99.26 5,392,280 535,237,724 0 Nov 25, 2020, 05:53 PM
Fasman Steven L SVP & General Counsel Nov 11, 2020 Sale $100.99 2,425 244,901 73,496 Nov 12, 2020, 12:21 PM
Schmidt Kay A SVP, Technical Operations Oct 23, 2020 Option Exercise $94.02 425 39,958 15,339 Oct 26, 2020, 06:51 PM
Schmidt Kay A SVP, Technical Operations Oct 14, 2020 Sale $93.15 2,985 278,045 17,564 Oct 16, 2020, 06:13 PM
Fasman Steven L SVP & General Counsel Oct 14, 2020 Option Exercise $93.10 9,515 885,883 81,431 Oct 16, 2020, 06:13 PM
Fasman Steven L SVP & General Counsel Oct 14, 2020 Option Exercise $26.18 15,025 393,426 87,460 Oct 16, 2020, 06:13 PM
Fasman Steven L SVP & General Counsel Oct 14, 2020 Sale $93.09 5,510 512,934 78,942 Oct 16, 2020, 06:13 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Oct 12, 2020 Sale $94.99 1,680 159,583 17,202 Oct 13, 2020, 08:24 AM
Arnold Jonathan Pres. Oral & Specialty Deliv. Oct 07, 2020 Option Exercise $91.50 23,414 2,142,381 54,546 Oct 09, 2020, 03:24 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Oct 07, 2020 Option Exercise $30.84 39,342 1,213,364 77,960 Oct 09, 2020, 03:24 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Oct 07, 2020 Sale $91.50 15,928 1,457,412 38,618 Oct 09, 2020, 03:24 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Oct 04, 2020 Option Exercise $85.88 240 20,611 38,618 Oct 06, 2020, 09:25 PM
Gunther Scott SVP, Quality & Reg. Affairs Oct 02, 2020 Option Exercise $84.94 5,200 441,688 21,049 Oct 05, 2020, 07:55 PM
Gunther Scott SVP, Quality & Reg. Affairs Oct 02, 2020 Option Exercise $36.02 7,347 264,639 26,249 Oct 05, 2020, 07:55 PM
Gunther Scott SVP, Quality & Reg. Affairs Oct 02, 2020 Sale $85.48 4,359 372,608 18,384 Oct 05, 2020, 07:55 PM
Chiminski John R Chair & CEO Oct 02, 2020 Option Exercise $86.01 86,251 7,418,449 355,849 Oct 05, 2020, 07:55 PM
Chiminski John R Chair & CEO Oct 02, 2020 Option Exercise $29.90 138,135 4,130,817 404,337 Oct 05, 2020, 07:55 PM
Chiminski John R Chair & CEO Oct 02, 2020 Sale $86.01 182,231 15,673,809 346,658 Oct 05, 2020, 07:55 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Sep 02, 2020 Sale $89.50 2,250 201,378 18,888 Sep 08, 2020, 01:21 PM
Schmidt Kay A SVP, Technical Operations Aug 27, 2020 Option Exercise $87.71 904 79,290 18,749 Aug 31, 2020, 05:25 PM
Pravda Ricardo SVP & Chief HR Officer Aug 27, 2020 Option Exercise $87.71 943 82,711 11,699 Aug 31, 2020, 05:24 PM
Maselli Alessandro President & COO Aug 27, 2020 Option Exercise $87.71 4,217 369,873 19,766 Aug 31, 2020, 05:24 PM
Joseph Wetteny SVP & Chief Financial Officer Aug 27, 2020 Option Exercise $87.71 3,480 305,231 54,599 Aug 31, 2020, 05:24 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 27, 2020 Option Exercise $87.71 2,823 247,605 18,902 Aug 31, 2020, 05:23 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Aug 27, 2020 Option Exercise $87.71 2,392 209,802 21,132 Aug 31, 2020, 05:23 PM
Gennadios Aristippos President Softgel & Oral Tech Aug 27, 2020 Option Exercise $87.71 4,384 384,521 51,425 Aug 31, 2020, 05:23 PM
Fasman Steven L SVP & General Counsel Aug 27, 2020 Option Exercise $87.71 6,676 585,552 75,883 Aug 31, 2020, 05:22 PM
Chiminski John R Chair & CEO Aug 27, 2020 Option Exercise $87.71 58,978 5,172,960 303,965 Aug 31, 2020, 05:22 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Aug 27, 2020 Option Exercise $87.71 3,023 265,147 38,858 Aug 31, 2020, 05:21 PM
Kreuzburg Christa Director Aug 22, 2020 Option Exercise $86.49 951 82,252 5,979 Aug 24, 2020, 06:16 PM
Chiminski John R Chair & CEO Aug 23, 2020 Option Exercise $86.49 4,649 402,092 223,918 Aug 24, 2020, 06:15 PM
LUCIER GREGORY T Director Jul 30, 2020 Sale $90.09 24,000 2,162,160 16,921 Aug 03, 2020, 12:02 PM
Schmidt Kay A SVP, Technical Operations Jul 24, 2020 Option Exercise $81.64 504 41,147 11,517 Jul 28, 2020, 08:12 AM
Pravda Ricardo SVP & Chief HR Officer Jul 24, 2020 Option Exercise $81.64 1,949 159,116 9,123 Jul 28, 2020, 08:12 AM
Maselli Alessandro President & COO Jul 24, 2020 Option Exercise $81.64 940 76,742 12,177 Jul 28, 2020, 08:11 AM
Joseph Wetteny SVP & Chief Financial Officer Jul 24, 2020 Option Exercise $81.64 761 62,128 46,015 Jul 28, 2020, 08:11 AM
Gunther Scott SVP, Quality & Reg. Affairs Jul 24, 2020 Option Exercise $81.64 646 52,739 12,719 Jul 28, 2020, 08:11 AM
Grippo Michael J SVP, Strategy & Corp. Dev. Jul 24, 2020 Option Exercise $81.64 532 43,432 15,750 Jul 28, 2020, 08:11 AM
Gennadios Aristippos President Softgel & Oral Tech Jul 24, 2020 Option Exercise $81.64 984 80,334 43,536 Jul 28, 2020, 08:10 AM
Fasman Steven L SVP & General Counsel Jul 24, 2020 Option Exercise $81.64 1,227 100,172 62,039 Jul 28, 2020, 08:10 AM
Chiminski John R Chair & CEO Jul 24, 2020 Option Exercise $81.64 6,642 542,253 207,965 Jul 28, 2020, 08:10 AM
Arnold Jonathan Pres. Oral & Specialty Deliv. Jul 24, 2020 Option Exercise $81.64 3,796 309,905 30,713 Jul 28, 2020, 08:09 AM
Gunther Scott SVP, Quality & Reg. Affairs Jun 29, 2020 Sale $72.00 2,824 203,318 13,765 Jul 01, 2020, 06:15 PM
Gennadios Aristippos President Softgel & Oral Tech Jun 25, 2020 Option Exercise $73.00 13,930 1,016,890 52,845 Jun 29, 2020, 06:54 PM
Gennadios Aristippos President Softgel & Oral Tech Jun 25, 2020 Option Exercise $27.97 22,255 622,541 59,736 Jun 29, 2020, 06:54 PM
Gennadios Aristippos President Softgel & Oral Tech Jun 25, 2020 Sale $73.00 8,325 607,725 44,520 Jun 29, 2020, 06:54 PM
CARROLL J MARTIN Director May 12, 2020 Option Exercise $72.29 3,600 260,244 8,527 May 13, 2020, 05:08 PM
CARROLL J MARTIN Director May 12, 2020 Option Exercise $72.29 3,600 260,244 0 May 13, 2020, 05:08 PM
Whitlow Ricci S President, CSS Apr 09, 2020 Option Exercise $56.46 240 13,550 2,704 Apr 13, 2020, 12:22 PM
Schmidt Kay A SVP, Technical Operations Apr 09, 2020 Option Exercise $56.46 226 12,760 12,021 Apr 13, 2020, 12:22 PM
Pravda Ricardo SVP & Chief HR Officer Apr 09, 2020 Option Exercise $56.46 226 12,760 11,072 Apr 13, 2020, 12:21 PM
Maselli Alessandro President & COO Apr 09, 2020 Option Exercise $56.46 315 17,785 13,117 Apr 13, 2020, 12:21 PM
Joseph Wetteny SVP & Chief Financial Officer Apr 09, 2020 Option Exercise $56.46 349 19,705 46,776 Apr 13, 2020, 12:20 PM
Gunther Scott SVP, Quality & Reg. Affairs Apr 09, 2020 Option Exercise $56.46 243 13,720 16,189 Apr 13, 2020, 12:20 PM
Grippo Michael J SVP, Strategy & Corp. Dev. Apr 09, 2020 Option Exercise $56.46 256 14,454 16,282 Apr 13, 2020, 12:20 PM
Gennadios Aristippos President Softgel & Oral Tech Apr 09, 2020 Option Exercise $56.46 279 15,752 44,520 Apr 13, 2020, 12:19 PM
Flynn Karen Pres. Biologics & CCO Apr 09, 2020 Option Exercise $56.46 359 20,269 35,645 Apr 13, 2020, 12:19 PM
Fasman Steven L SVP & General Counsel Apr 09, 2020 Option Exercise $56.46 386 21,794 63,206 Apr 13, 2020, 12:19 PM
BUZY PETER L President, Gene Therapy Apr 09, 2020 Option Exercise $56.46 266 15,018 45,950 Apr 13, 2020, 12:12 PM
Arnold Jonathan Pres. Oral & Specialty Deliv. Apr 09, 2020 Option Exercise $56.46 264 14,905 34,509 Apr 13, 2020, 12:12 PM
LUCIER GREGORY T Director Feb 13, 2020 Buy $59.71 2,000 119,420 40,921 Feb 14, 2020, 02:43 PM
Schmidt Kay A SVP, Technical Operations Feb 02, 2020 Option Exercise $61.10 207 12,648 11,795 Feb 04, 2020, 06:22 PM
Maselli Alessandro President & COO Dec 16, 2019 Sale $53.18 7,268 386,512 12,802 Dec 18, 2019, 08:51 AM
Pravda Ricardo SVP & Chief HR Officer Nov 26, 2019 Sale $52.73 2,612 137,718 12,161 Nov 27, 2019, 11:36 AM
Gennadios Aristippos President Softgel & Oral Tech Nov 25, 2019 Option Exercise $52.55 78,615 4,131,218 89,497 Nov 27, 2019, 11:36 AM
Gennadios Aristippos President Softgel & Oral Tech Nov 25, 2019 Option Exercise $18.35 123,880 2,272,760 141,122 Nov 27, 2019, 11:36 AM
Gennadios Aristippos President Softgel & Oral Tech Nov 25, 2019 Sale $52.55 45,256 2,378,203 44,241 Nov 27, 2019, 11:36 AM
Grippo Michael J SVP, Strategy & Corp. Dev. Nov 22, 2019 Sale $52.00 376 19,552 10,702 Nov 26, 2019, 05:07 PM
Chiminski John R Chair & CEO Oct 07, 2019 Option Exercise $48.84 34,089 1,664,907 321,300 Oct 09, 2019, 01:13 PM
Chiminski John R Chair & CEO Oct 07, 2019 Option Exercise $24.40 47,552 1,160,409 348,387 Oct 09, 2019, 01:13 PM
Chiminski John R Chair & CEO Oct 07, 2019 Sale $48.84 97,043 4,739,580 224,257 Oct 09, 2019, 01:13 PM
LUCIER GREGORY T Director Sep 09, 2019 Buy $51.64 2,000 103,280 38,921 Sep 11, 2019, 08:30 AM
Maselli Alessandro President & COO Sep 09, 2019 Option Exercise $52.48 3,299 173,132 20,070 Sep 11, 2019, 08:19 AM
Schmidt Kay A SVP, Technical Operations Aug 22, 2019 Option Exercise $55.24 1,153 63,692 12,002 Aug 26, 2019, 03:51 PM
Pravda Ricardo SVP, Human Resources Aug 22, 2019 Option Exercise $55.24 1,218 67,282 13,458 Aug 26, 2019, 03:50 PM
Maselli Alessandro President & COO Aug 22, 2019 Option Exercise $55.24 5,466 301,942 23,369 Aug 26, 2019, 03:50 PM
Littlejohns Barry President, Biologics & SDD Aug 22, 2019 Option Exercise $55.24 7,178 396,513 45,882 Aug 26, 2019, 03:49 PM
Kreuzburg Christa Director Aug 23, 2019 Option Exercise $53.15 1,255 66,703 6,930 Aug 26, 2019, 03:49 PM
Joseph Wetteny SVP & Chief Financial Officer Aug 22, 2019 Option Exercise $55.24 4,176 230,682 46,427 Aug 26, 2019, 03:48 PM
HEGWOOD PAUL W JR President, CSS Aug 22, 2019 Option Exercise $55.24 1,069 59,052 11,848 Aug 26, 2019, 03:48 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 22, 2019 Option Exercise $55.24 1,317 72,751 15,946 Aug 26, 2019, 03:48 PM
Gennadios Aristippos President, Softgel Tech. Aug 22, 2019 Option Exercise $55.24 3,805 210,188 44,232 Aug 26, 2019, 03:47 PM
Fasman Steven L SVP & General Counsel Aug 22, 2019 Option Exercise $55.24 8,921 492,796 62,628 Aug 26, 2019, 03:47 PM
Chiminski John R Chair & CEO Aug 22, 2019 Option Exercise $55.24 51,767 2,859,609 307,837 Aug 26, 2019, 03:45 PM
Arnold Jonathan President, Oral Drug Delivery Aug 22, 2019 Option Exercise $55.24 2,765 152,739 34,245 Aug 26, 2019, 03:44 PM
Schmidt Kay A SVP, Technical Operations Jul 26, 2019 Option Exercise $57.26 1,079 61,784 9,558 Jul 30, 2019, 04:22 PM
Pravda Ricardo SVP, Human Resources Jul 26, 2019 Option Exercise $57.26 1,498 85,775 11,123 Jul 30, 2019, 04:22 PM
Maselli Alessandro President & COO Jul 26, 2019 Option Exercise $57.26 984 56,344 17,209 Jul 30, 2019, 04:22 PM
Littlejohns Barry President, Biologics & SDD Jul 26, 2019 Option Exercise $57.26 1,234 70,659 38,487 Jul 30, 2019, 04:21 PM
Joseph Wetteny SVP & Chief Financial Officer Jul 26, 2019 Option Exercise $57.26 954 54,626 39,342 Jul 30, 2019, 04:21 PM
HEGWOOD PAUL W JR President, CSS Jul 26, 2019 Option Exercise $57.26 1,318 75,469 9,180 Jul 30, 2019, 04:21 PM
Gunther Scott SVP, Quality & Reg. Affairs Jul 26, 2019 Option Exercise $57.26 1,626 93,105 13,419 Jul 30, 2019, 04:20 PM
Gennadios Aristippos President, Softgel Tech. Jul 26, 2019 Option Exercise $57.26 748 42,830 35,617 Jul 30, 2019, 04:20 PM
Fasman Steven L SVP & General Counsel Jul 26, 2019 Option Exercise $57.26 2,205 126,258 53,332 Jul 30, 2019, 04:20 PM
Chiminski John R Chair & CEO Jul 26, 2019 Option Exercise $57.26 13,333 763,448 240,384 Jul 30, 2019, 04:19 PM
Arnold Jonathan President, Oral Drug Delivery Jul 26, 2019 Option Exercise $57.26 2,394 137,080 28,000 Jul 30, 2019, 04:19 PM
CARROLL J MARTIN Director Jul 15, 2019 Option Exercise $53.24 4,927 262,313 4,927 Jul 17, 2019, 06:53 PM
CARROLL J MARTIN Director Jul 15, 2019 Option Exercise $53.24 4,927 262,313 0 Jul 17, 2019, 06:53 PM
Littlejohns Barry President, Biologics & SDD Jul 12, 2019 Option Exercise $53.54 33,272 1,781,383 53,658 Jul 16, 2019, 07:21 PM
Littlejohns Barry President, Biologics & SDD Jul 12, 2019 Option Exercise $19.36 49,212 952,938 67,562 Jul 16, 2019, 07:21 PM
Littlejohns Barry President, Biologics & SDD Jul 12, 2019 Sale $53.53 15,940 853,344 37,818 Jul 16, 2019, 07:21 PM
Fasman Steven L SVP & General Counsel Jul 11, 2019 Option Exercise $54.01 19,040 1,028,350 52,581 Jul 15, 2019, 06:03 PM
Fasman Steven L SVP & General Counsel Jul 11, 2019 Option Exercise $27.30 27,146 741,142 60,705 Jul 15, 2019, 06:03 PM
Fasman Steven L SVP & General Counsel Jul 11, 2019 Sale $54.04 4,053 219,024 48,528 Jul 15, 2019, 06:03 PM
BUZY PETER L President, Gene Therapy May 29, 2019 Buy $45.13 44,500 2,008,285 44,500 May 30, 2019, 07:36 PM
Joseph Wetteny SVP & Chief Financial Officer May 28, 2019 Option Exercise $46.23 4,677 216,218 37,383 May 30, 2019, 06:54 PM
Joseph Wetteny SVP & Chief Financial Officer May 28, 2019 Option Exercise $10.71 9,453 101,242 42,060 May 30, 2019, 06:54 PM
MOREL DONALD E JR Director May 15, 2019 Buy $44.44 10,000 444,400 46,958 May 16, 2019, 07:51 PM
LUCIER GREGORY T Director May 09, 2019 Buy $45.08 2,000 90,160 38,822 May 13, 2019, 01:39 PM
Gennadios Aristippos President, Softgel Tech. Mar 21, 2019 Option Exercise $42.17 6,744 284,385 39,068 Mar 25, 2019, 05:50 PM
Gennadios Aristippos President, Softgel Tech. Mar 21, 2019 Option Exercise $10.71 13,528 144,885 44,862 Mar 25, 2019, 05:50 PM
Gennadios Aristippos President, Softgel Tech. Mar 21, 2019 Sale $42.18 3,392 143,089 34,792 Mar 25, 2019, 05:50 PM
Miyamoto Lance SVP, Human Resources Mar 07, 2019 Option Exercise $42.64 79,991 3,410,816 90,418 Mar 11, 2019, 07:31 PM
Miyamoto Lance SVP, Human Resources Mar 07, 2019 Option Exercise $15.34 123,610 1,896,336 130,793 Mar 11, 2019, 07:31 PM
Miyamoto Lance SVP, Human Resources Mar 07, 2019 Sale $42.49 43,619 1,853,379 46,918 Mar 11, 2019, 07:31 PM
Kreuzburg Christa Director Feb 16, 2019 Option Exercise $42.03 358 15,047 5,018 Feb 20, 2019, 03:53 PM
Downie William SVP, Global Sales & Marketing Feb 15, 2019 Option Exercise $42.00 9,736 408,912 42,241 Feb 20, 2019, 03:48 PM
Downie William SVP, Global Sales & Marketing Feb 15, 2019 Option Exercise $24.69 12,457 307,505 45,231 Feb 20, 2019, 03:48 PM
Downie William SVP, Global Sales & Marketing Feb 15, 2019 Sale $42.00 7,315 307,230 34,926 Feb 20, 2019, 03:48 PM
Fasman Steven L SVP & General Counsel Jan 28, 2019 Option Exercise $36.49 5,199 189,712 44,475 Jan 30, 2019, 01:29 PM
GREISCH JOHN J Director Nov 08, 2018 Buy $37.61 13,000 488,930 13,000 Nov 13, 2018, 08:28 AM
Miyamoto Lance SVP, Human Resources Oct 16, 2018 Option Exercise $42.50 11,475 487,688 53,324 Oct 18, 2018, 11:59 AM
Miyamoto Lance SVP, Human Resources Oct 16, 2018 Option Exercise $12.14 18,000 218,520 64,799 Oct 18, 2018, 11:59 AM
Miyamoto Lance SVP, Human Resources Oct 16, 2018 Sale $42.50 6,525 277,313 46,799 Oct 18, 2018, 11:59 AM
Littlejohns Barry President, Biologics & SDD Oct 15, 2018 Option Exercise $41.64 97,546 4,061,815 84,983 Oct 17, 2018, 12:28 PM
Littlejohns Barry President, Biologics & SDD Oct 15, 2018 Option Exercise $14.86 144,811 2,151,891 125,218 Oct 17, 2018, 12:28 PM
Littlejohns Barry President, Biologics & SDD Oct 15, 2018 Sale $41.64 47,265 1,968,115 37,718 Oct 17, 2018, 12:28 PM
Joseph Wetteny SVP & Chief Financial Officer Oct 15, 2018 Option Exercise $41.47 303 12,565 32,607 Oct 16, 2018, 03:55 PM
Chiminski John R Chair, President & CEO Oct 01, 2018 Option Exercise $45.32 199,608 9,046,234 360,235 Oct 03, 2018, 05:53 PM
Chiminski John R Chair, President & CEO Oct 01, 2018 Option Exercise $21.05 286,358 6,027,735 416,074 Oct 03, 2018, 05:53 PM
Chiminski John R Chair, President & CEO Oct 01, 2018 Sale $45.32 130,545 5,916,299 229,690 Oct 03, 2018, 05:53 PM
MOREL DONALD E JR Director Sep 13, 2018 Buy $43.00 10,000 430,000 36,958 Sep 17, 2018, 10:56 AM
Miyamoto Lance SVP, Human Resources Aug 27, 2018 Option Exercise $43.66 987 43,092 46,799 Sep 04, 2018, 07:53 PM
Maselli Alessandro SVP, Global Operations Aug 27, 2018 Option Exercise $43.66 427 18,643 15,644 Sep 04, 2018, 07:53 PM
Littlejohns Barry President, Biologics & SDD Aug 27, 2018 Option Exercise $43.66 944 41,215 37,718 Sep 04, 2018, 07:52 PM
Joseph Wetteny SVP & Chief Financial Officer Aug 27, 2018 Option Exercise $43.66 502 21,917 32,910 Sep 04, 2018, 07:51 PM
HEGWOOD PAUL W JR President, CSS Aug 27, 2018 Option Exercise $43.66 505 22,048 9,587 Sep 04, 2018, 07:51 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 27, 2018 Option Exercise $43.66 590 25,759 13,807 Sep 04, 2018, 07:50 PM
Fasman Steven L SVP & General Counsel Aug 27, 2018 Option Exercise $43.66 1,063 46,411 49,674 Sep 04, 2018, 07:50 PM
Downie William SVP, Global Sales & Marketing Aug 27, 2018 Option Exercise $43.66 1,291 56,365 39,520 Sep 04, 2018, 07:49 PM
Chiminski John R Chair, President & CEO Aug 27, 2018 Option Exercise $43.66 9,783 427,126 278,353 Sep 04, 2018, 07:48 PM
Arnold Jonathan President, Oral Drug Delivery Aug 27, 2018 Option Exercise $43.66 518 22,616 32,696 Sep 04, 2018, 07:48 PM
Miyamoto Lance SVP, Human Resources Aug 27, 2018 Option Exercise $43.66 987 43,092 48,773 Aug 29, 2018, 04:51 PM
Maselli Alessandro SVP, Global Operations Aug 27, 2018 Option Exercise $43.66 427 18,643 16,498 Aug 29, 2018, 04:51 PM
Littlejohns Barry President, Biologics & SDD Aug 27, 2018 Option Exercise $43.66 944 41,215 39,606 Aug 29, 2018, 04:50 PM
Joseph Wetteny SVP & Chief Financial Officer Aug 27, 2018 Option Exercise $43.66 502 21,917 33,914 Aug 29, 2018, 04:49 PM
HEGWOOD PAUL W JR President, CSS Aug 27, 2018 Option Exercise $43.66 505 22,048 10,597 Aug 29, 2018, 04:49 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 27, 2018 Option Exercise $43.66 590 25,759 14,987 Aug 29, 2018, 04:48 PM
Fasman Steven L SVP & General Counsel Aug 27, 2018 Option Exercise $43.66 1,063 46,411 51,800 Aug 29, 2018, 04:48 PM
Downie William SVP, Global Sales & Marketing Aug 27, 2018 Option Exercise $43.66 1,291 56,365 42,102 Aug 29, 2018, 04:47 PM
Chiminski John R Chair, President & CEO Aug 27, 2018 Option Exercise $43.66 9,783 427,126 297,919 Aug 29, 2018, 04:46 PM
Arnold Jonathan President, Oral Drug Delivery Aug 27, 2018 Option Exercise $43.66 518 22,616 33,732 Aug 29, 2018, 04:46 PM
Miyamoto Lance SVP, Human Resources Aug 23, 2018 Option Exercise $41.83 2,129 89,056 47,786 Aug 27, 2018, 05:25 PM
Maselli Alessandro SVP, Global Operations Aug 23, 2018 Option Exercise $41.83 369 15,435 16,071 Aug 27, 2018, 05:24 PM
Littlejohns Barry President, Biologics & SDD Aug 23, 2018 Option Exercise $41.83 2,037 85,208 38,662 Aug 27, 2018, 05:23 PM
Joseph Wetteny SVP & Chief Financial Officer Aug 23, 2018 Option Exercise $41.83 1,835 76,758 33,412 Aug 27, 2018, 05:23 PM
HEGWOOD PAUL W JR President, CSS Aug 23, 2018 Option Exercise $41.83 435 18,196 10,092 Aug 27, 2018, 05:22 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 23, 2018 Option Exercise $41.83 511 21,375 14,397 Aug 27, 2018, 05:22 PM
Fasman Steven L SVP & General Counsel Aug 23, 2018 Option Exercise $41.83 2,295 96,000 50,737 Aug 27, 2018, 05:20 PM
Downie William SVP, Global Sales & Marketing Aug 23, 2018 Option Exercise $41.83 2,787 116,580 40,811 Aug 27, 2018, 05:20 PM
Chiminski John R Chair, President & CEO Aug 23, 2018 Option Exercise $41.83 17,561 734,577 288,136 Aug 27, 2018, 05:19 PM
Arnold Jonathan President, Oral Drug Delivery Aug 23, 2018 Option Exercise $41.83 1,117 46,724 33,214 Aug 27, 2018, 05:19 PM
Fasman Steven L SVP & General Counsel Jun 20, 2018 Option Exercise $41.78 10,954 457,658 45,568 Jun 21, 2018, 12:46 PM
Fasman Steven L SVP & General Counsel Jun 20, 2018 Option Exercise $24.26 15,458 375,011 56,522 Jun 21, 2018, 12:46 PM
Fasman Steven L SVP & General Counsel Jun 20, 2018 Sale $41.78 2,252 94,089 43,316 Jun 21, 2018, 12:46 PM
Downie William SVP, Global Sales & Marketing Mar 08, 2018 Option Exercise $40.95 12,965 530,917 44,475 Mar 12, 2018, 11:44 AM
Downie William SVP, Global Sales & Marketing Mar 08, 2018 Option Exercise $26.12 15,515 405,239 49,188 Mar 12, 2018, 11:44 AM
Downie William SVP, Global Sales & Marketing Mar 08, 2018 Sale $41.80 9,082 379,628 35,393 Mar 12, 2018, 11:44 AM
Chiminski John R Chair, President & CEO Dec 11, 2017 Option Exercise $39.70 125,227 4,971,512 411,539 Dec 13, 2017, 02:37 PM
Chiminski John R Chair, President & CEO Dec 11, 2017 Option Exercise $10.71 206,685 2,213,596 536,766 Dec 13, 2017, 02:37 PM
Chiminski John R Chair, President & CEO Dec 12, 2017 Sale $39.51 78,190 3,089,287 230,081 Dec 13, 2017, 02:37 PM
Chiminski John R Chair, President & CEO Dec 11, 2017 Sale $39.70 103,268 4,099,740 330,081 Dec 13, 2017, 02:37 PM
Roehrhoff Uwe Director Nov 21, 2017 Buy $39.22 7,500 294,150 16,489 Nov 22, 2017, 04:25 PM
Fasman Steven L SVP & General Counsel Oct 23, 2017 Option Exercise $42.74 1,602 68,469 36,064 Oct 25, 2017, 12:32 PM
Chiminski John R Chair, President & CEO Oct 23, 2017 Option Exercise $42.74 3,604 154,035 330,081 Oct 25, 2017, 12:32 PM
Chiminski John R Chair, President & CEO Sep 16, 2017 Option Exercise $39.49 22,039 870,320 333,685 Sep 18, 2017, 07:53 PM
Miyamoto Lance SVP - Human Resources Aug 29, 2017 Option Exercise $38.22 23,342 892,131 49,593 Aug 31, 2017, 03:43 PM
Miyamoto Lance SVP - Human Resources Aug 29, 2017 Option Exercise $12.14 39,138 475,135 60,935 Aug 31, 2017, 03:43 PM
Miyamoto Lance SVP - Human Resources Aug 29, 2017 Sale $38.22 8,512 325,329 41,081 Aug 31, 2017, 03:43 PM
Dolan Christine SVP - Product Development Aug 29, 2017 Option Exercise $38.75 5,964 231,105 21,043 Aug 31, 2017, 10:41 AM
Dolan Christine SVP - Product Development Aug 29, 2017 Option Exercise $18.57 9,150 169,915 27,007 Aug 31, 2017, 10:41 AM
Dolan Christine SVP - Product Development Aug 29, 2017 Sale $38.75 1,594 61,768 19,449 Aug 31, 2017, 10:41 AM
WALSH MATTHEW M EVP & Chief Financial Officer Aug 24, 2017 Option Exercise $35.21 8,245 290,306 103,703 Aug 28, 2017, 12:29 PM
Miyamoto Lance SVP - Human Resources Aug 24, 2017 Option Exercise $35.21 3,604 126,897 33,797 Aug 28, 2017, 12:29 PM
Maselli Alessandro SVP - Global Operations Aug 24, 2017 Option Exercise $35.21 718 25,281 13,603 Aug 28, 2017, 12:29 PM
Littlejohns Barry President - DDS Aug 24, 2017 Option Exercise $35.21 3,400 119,714 32,249 Aug 28, 2017, 12:28 PM
Joseph Wetteny President - CSS Aug 24, 2017 Option Exercise $35.21 1,822 64,153 14,277 Aug 28, 2017, 12:28 PM
Gunther Scott SVP, Quality & Reg. Affairs Aug 24, 2017 Option Exercise $35.21 869 30,597 11,870 Aug 28, 2017, 12:28 PM
Gennadios Aristippos See Remarks Aug 24, 2017 Option Exercise $35.21 2,633 92,708 22,525 Aug 28, 2017, 12:27 PM
Fasman Steven L See Remarks Aug 24, 2017 Option Exercise $35.21 3,828 134,784 37,666 Aug 28, 2017, 12:27 PM
Downie William SVP, Global Sales & Marketing Aug 24, 2017 Option Exercise $35.21 5,644 198,725 41,925 Aug 28, 2017, 12:27 PM
Dolan Christine SVP - Product Development Aug 24, 2017 Option Exercise $35.21 1,881 66,230 17,857 Aug 28, 2017, 12:26 PM
Chiminski John R President & CEO Aug 24, 2017 Option Exercise $35.21 19,472 685,609 355,724 Aug 28, 2017, 12:26 PM
Dolan Christine SVP - Product Development Aug 01, 2017 Sale $34.85 745 25,963 14,058 Aug 03, 2017, 05:31 PM
WALSH MATTHEW M EVP & Chief Financial Officer Jul 31, 2017 Option Exercise $34.97 3,230 112,953 95,757 Aug 01, 2017, 06:35 PM
Miyamoto Lance SVP - Human Resources Jul 31, 2017 Option Exercise $34.97 1,412 49,378 26,441 Aug 01, 2017, 06:35 PM
Maselli Alessandro SVP - Global Operations Jul 31, 2017 Option Exercise $34.97 703 24,584 12,802 Aug 01, 2017, 06:35 PM
Littlejohns Barry President - DDS Jul 31, 2017 Option Exercise $34.97 1,332 46,580 25,311 Aug 01, 2017, 06:34 PM
Joseph Wetteny President - CSS Jul 31, 2017 Option Exercise $34.97 712 24,899 10,558 Aug 01, 2017, 06:34 PM
Gunther Scott SVP, Quality & Reg. Affairs Jul 31, 2017 Option Exercise $34.97 845 29,550 10,098 Aug 01, 2017, 06:34 PM
Downie William SVP, Global Sales & Marketing Jul 31, 2017 Option Exercise $34.97 2,211 77,319 37,231 Aug 01, 2017, 06:34 PM
Dolan Christine SVP - Product Development Jul 31, 2017 Option Exercise $34.97 734 25,668 14,803 Aug 01, 2017, 06:33 PM
Chiminski John R President & CEO Jul 31, 2017 Option Exercise $34.97 3,816 133,446 321,274 Aug 01, 2017, 06:33 PM
WALSH MATTHEW M See Remarks Jun 08, 2017 Option Exercise $37.01 46,903 1,735,814 121,460 Jun 12, 2017, 04:36 PM
WALSH MATTHEW M See Remarks Jun 08, 2017 Option Exercise $11.84 74,651 884,064 168,363 Jun 12, 2017, 04:36 PM
Johnson Sharon See Remarks Apr 25, 2017 Option Exercise $29.00 52,392 1,519,368 32,929 Apr 27, 2017, 11:02 AM
Johnson Sharon See Remarks Apr 25, 2017 Option Exercise $14.82 70,716 1,047,668 53,670 Apr 27, 2017, 11:02 AM
Johnson Sharon See Remarks Apr 25, 2017 Sale $29.00 9,160 265,640 30,829 Apr 27, 2017, 11:02 AM
Downie William See Remarks Mar 20, 2017 Option Exercise $28.63 41,578 1,190,398 40,731 Mar 22, 2017, 07:06 PM
Downie William See Remarks Mar 20, 2017 Option Exercise $13.27 58,103 770,994 64,147 Mar 22, 2017, 07:06 PM
Downie William See Remarks Mar 20, 2017 Sale $28.60 8,262 236,293 36,665 Mar 22, 2017, 07:06 PM
Chiminski John R See Remarks Mar 16, 2017 Option Exercise $28.50 132,865 3,786,653 260,326 Mar 20, 2017, 05:31 PM
Chiminski John R See Remarks Mar 16, 2017 Option Exercise $10.71 206,684 2,213,586 393,191 Mar 20, 2017, 05:31 PM
Chiminski John R See Remarks Mar 16, 2017 Sale $28.62 73,618 2,106,756 191,492 Mar 20, 2017, 05:31 PM
Chiminski John R See Remarks Mar 20, 2017 Sale $28.76 201 5,781 186,507 Mar 20, 2017, 05:31 PM
MOREL DONALD E JR Director Feb 15, 2017 Buy $29.27 10,000 292,700 18,799 Feb 16, 2017, 04:42 PM
Blackstone Management Associates V L.L.C. 10% Owner Sep 09, 2016 Sale $23.58 17,100,705 403,234,623 0 Sep 13, 2016, 06:07 PM
Blackstone Management Associates V L.L.C. 10% Owner Jun 09, 2016 Sale $24.51 8,785,539 215,333,563 17,100,705 Jun 13, 2016, 05:00 PM
WALSH MATTHEW M See Remarks May 27, 2016 Option Exercise $28.85 67,927 1,959,694 101,443 Jun 01, 2016, 05:35 PM
WALSH MATTHEW M See Remarks May 27, 2016 Option Exercise $15.69 89,124 1,398,010 140,688 Jun 01, 2016, 05:35 PM
WALSH MATTHEW M See Remarks May 27, 2016 Sale $28.85 21,197 611,533 88,188 Jun 01, 2016, 05:35 PM
CARROLL J MARTIN Director Sep 04, 2015 Option Exercise $27.26 3,000 81,780 6,928 Sep 09, 2015, 02:50 PM
Chiminski John R See Remarks Aug 17, 2015 Option Exercise $33.80 61,495 2,078,531 378,623 Aug 19, 2015, 06:02 PM
Chiminski John R See Remarks Aug 17, 2015 Option Exercise $10.71 100,000 1,071,000 440,118 Aug 19, 2015, 06:02 PM
Chiminski John R See Remarks Aug 19, 2015 Sale $33.93 2,955 100,263 340,118 Aug 19, 2015, 06:02 PM
Chiminski John R See Remarks Aug 17, 2015 Sale $33.80 35,550 1,201,590 343,073 Aug 19, 2015, 06:02 PM
Chiminski John R See Remarks Aug 03, 2015 Option Exercise $33.85 64,723 2,190,873 375,395 Aug 05, 2015, 04:28 PM
Chiminski John R See Remarks Aug 03, 2015 Option Exercise $10.71 100,000 1,071,000 440,118 Aug 05, 2015, 04:28 PM
Chiminski John R See Remarks Aug 03, 2015 Sale $33.85 35,277 1,194,126 340,118 Aug 05, 2015, 04:28 PM
WALSH MATTHEW M See Remarks Jul 27, 2015 Option Exercise $30.50 57,545 1,755,123 99,740 Jul 29, 2015, 01:58 PM
WALSH MATTHEW M See Remarks Jul 27, 2015 Option Exercise $11.50 84,717 974,229 130,880 Jul 29, 2015, 01:58 PM
WALSH MATTHEW M See Remarks Jul 27, 2015 Sale $31.18 27,172 847,223 84,120 Jul 29, 2015, 01:58 PM
Chiminski John R See Remarks Jul 20, 2015 Option Exercise $29.40 66,919 1,967,419 359,140 Jul 22, 2015, 01:54 PM
Chiminski John R See Remarks Jul 20, 2015 Option Exercise $10.71 100,000 1,071,000 397,618 Jul 22, 2015, 01:54 PM
Chiminski John R See Remarks Jul 20, 2015 Sale $29.40 33,081 972,581 340,118 Jul 22, 2015, 01:54 PM
Chiminski John R See Remarks Jul 06, 2015 Option Exercise $29.34 66,172 1,941,486 373,946 Jul 08, 2015, 08:42 AM
Chiminski John R See Remarks Jul 06, 2015 Option Exercise $10.71 100,000 1,071,000 440,118 Jul 08, 2015, 08:42 AM
Chiminski John R See Remarks Jul 06, 2015 Sale $29.34 33,828 992,514 340,118 Jul 08, 2015, 08:42 AM
Blackstone Management Associates V L.L.C. 10% Owner Jun 11, 2015 Sale $28.13 1,844,963 51,898,808 25,886,244 Jun 11, 2015, 05:00 PM
Blackstone Management Associates V L.L.C. 10% Owner Jun 08, 2015 Sale $28.13 12,299,753 345,992,042 27,731,207 Jun 10, 2015, 05:00 PM
WALSH MATTHEW M See Remarks Apr 06, 2015 Option Exercise $30.43 67,987 2,068,844 116,559 Apr 08, 2015, 11:08 AM
WALSH MATTHEW M See Remarks Apr 06, 2015 Option Exercise $10.71 102,043 1,092,881 184,546 Apr 08, 2015, 11:08 AM
WALSH MATTHEW M See Remarks Apr 06, 2015 Sale $30.43 34,439 1,047,979 84,120 Apr 08, 2015, 11:08 AM
Houlton Scott See Remarks Apr 01, 2015 Option Exercise $30.61 65,936 2,018,301 37,973 Apr 03, 2015, 05:29 PM
Houlton Scott See Remarks Apr 01, 2015 Option Exercise $11.98 98,035 1,174,870 74,571 Apr 03, 2015, 05:29 PM
Houlton Scott See Remarks Apr 01, 2015 Sale $30.61 16,253 497,504 34,127 Apr 03, 2015, 05:29 PM
Gennadios Aristippos See Remarks Apr 01, 2015 Option Exercise $30.61 39,861 1,220,145 21,734 Apr 03, 2015, 05:00 PM
Gennadios Aristippos See Remarks Apr 01, 2015 Option Exercise $11.22 65,464 734,573 38,961 Apr 03, 2015, 05:00 PM
Gennadios Aristippos See Remarks Apr 01, 2015 Sale $30.61 24,868 761,209 8,651 Apr 03, 2015, 05:00 PM
WALSH MATTHEW M See Remarks Mar 27, 2015 Option Exercise $30.10 11,039 332,274 84,503 Mar 31, 2015, 06:23 PM
Leonard Stephen See Remarks Mar 27, 2015 Option Exercise $30.13 83,714 2,522,303 75,536 Mar 31, 2015, 06:11 PM
Leonard Stephen See Remarks Mar 27, 2015 Option Exercise $10.71 136,000 1,456,560 159,250 Mar 31, 2015, 06:11 PM
Leonard Stephen See Remarks Mar 27, 2015 Sale $30.13 31,005 934,181 44,531 Mar 31, 2015, 06:11 PM
Johnson Sharon See Remarks Feb 13, 2015 Option Exercise $27.83 33,300 926,739 25,523 Feb 19, 2015, 08:14 PM
Johnson Sharon See Remarks Feb 17, 2015 Option Exercise $27.40 53,169 1,456,831 39,596 Feb 19, 2015, 08:14 PM
Johnson Sharon See Remarks Feb 13, 2015 Option Exercise $10.71 49,400 529,074 46,473 Feb 19, 2015, 08:14 PM
Johnson Sharon See Remarks Feb 17, 2015 Option Exercise $11.00 77,852 856,691 90,383 Feb 19, 2015, 08:14 PM
Johnson Sharon See Remarks Feb 17, 2015 Sale $27.40 24,683 676,314 15,393 Feb 19, 2015, 08:14 PM
Johnson Sharon See Remarks Feb 13, 2015 Sale $27.82 16,100 447,962 15,393 Feb 19, 2015, 08:14 PM
Kurt Nielsen See Remarks Feb 17, 2015 Option Exercise $27.41 42,429 1,162,979 52,767 Feb 19, 2015, 07:28 PM
Kurt Nielsen See Remarks Feb 17, 2015 Option Exercise $10.71 71,520 765,979 95,196 Feb 19, 2015, 07:28 PM
Kurt Nielsen See Remarks Feb 17, 2015 Sale $27.41 29,091 797,384 23,676 Feb 19, 2015, 07:28 PM
Kurt Nielsen See Remarks Feb 17, 2015 Option Exercise $27.41 28,040 768,576 43,676 Feb 19, 2015, 09:39 AM
Kurt Nielsen See Remarks Feb 17, 2015 Option Exercise $10.71 48,040 514,508 71,716 Feb 19, 2015, 09:39 AM
Kurt Nielsen See Remarks Feb 17, 2015 Sale $27.41 20,000 548,200 23,676 Feb 19, 2015, 09:39 AM
Houlton Scott See Remarks Feb 13, 2015 Option Exercise $28.28 1,893 53,534 20 Feb 18, 2015, 09:28 PM
Houlton Scott See Remarks Feb 17, 2015 Option Exercise $27.42 18 494 31,419 Feb 18, 2015, 09:28 PM
Houlton Scott See Remarks Feb 13, 2015 Option Exercise $10.71 3,293 35,268 21,574 Feb 18, 2015, 09:28 PM
Houlton Scott See Remarks Feb 17, 2015 Option Exercise $10.71 31,210 334,259 49,491 Feb 18, 2015, 09:28 PM
Houlton Scott See Remarks Feb 17, 2015 Sale $27.42 13,138 360,244 18,281 Feb 18, 2015, 09:28 PM
Houlton Scott See Remarks Feb 13, 2015 Sale $28.28 1,400 39,592 18,281 Feb 18, 2015, 09:28 PM
Leonard Stephen See Remarks Feb 13, 2015 Option Exercise $28.34 1,508 42,737 24,250 Feb 18, 2015, 09:01 PM
Leonard Stephen See Remarks Feb 13, 2015 Option Exercise $10.71 2,508 26,861 25,758 Feb 18, 2015, 09:01 PM
Leonard Stephen See Remarks Feb 13, 2015 Sale $28.34 1,000 28,340 23,250 Feb 18, 2015, 09:01 PM
Downie William See Remarks Feb 13, 2015 Option Exercise $27.86 5,122 142,699 23,351 Feb 18, 2015, 08:39 PM
Downie William See Remarks Feb 17, 2015 Option Exercise $27.82 93,969 2,614,218 55,866 Feb 18, 2015, 08:39 PM
Downie William See Remarks Feb 17, 2015 Option Exercise $10.71 138,969 1,488,358 126,240 Feb 18, 2015, 08:39 PM
Downie William See Remarks Feb 13, 2015 Option Exercise $10.71 6,202 66,423 28,473 Feb 18, 2015, 08:39 PM
Downie William See Remarks Feb 13, 2015 Sale $27.86 1,080 30,089 22,271 Feb 18, 2015, 08:39 PM
Downie William See Remarks Feb 17, 2015 Sale $27.82 45,000 1,251,900 22,271 Feb 18, 2015, 08:39 PM
WALSH MATTHEW M See Remarks Feb 13, 2015 Sale $28.11 3,200 89,952 95,542 Feb 18, 2015, 06:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Zippelius Peter Director 11/18/2021 387,555,795
Zippelius Peter Director 11/30/2021 387,900,009
CARROLL J MARTIN Director 11/29/2021 420,600
CARROLL J MARTIN Director 11/29/2021 420,600
LUCIER GREGORY T Director 11/23/2021 645,407
Arnold Jonathan Pres. Oral & Specialty Deliv. 11/01/2021 338,421
Arnold Jonathan Pres. Oral & Specialty Deliv. 11/01/2021 1,494,293
Kreuzburg Christa Director 10/28/2021 86,449
Castellano Thomas P SVP, Chief Financial Officer 10/20/2021 309,138
Arnold Jonathan Pres. Oral & Specialty Deliv. 10/14/2021 214,950
Schmidt Kay A SVP, Technical Operations 10/04/2021 287,569
Fasman Steven L SVP & General Counsel 10/04/2021 889,050
Fasman Steven L SVP & General Counsel 10/04/2021 4,479,975
Pravda Ricardo SVP & Chief HR Officer 10/01/2021 241,694
Pravda Ricardo SVP & Chief HR Officer 10/01/2021 650,928
Grippo Michael J SVP, Strategy & Corp. Dev. 10/01/2021 270,557
Chiminski John R Chair & CEO 10/01/2021 2,986,973
Chiminski John R Chair & CEO 10/01/2021 19,979,610
Kreuzburg Christa Director 08/27/2021 25,840
Castellano Thomas P SVP, Chief Financial Officer 08/27/2021 274,458
Schmidt Kay A SVP, Technical Operations 08/27/2021 108,183
Hopson Ricky VP, Chief Accounting Officer 08/27/2021 192,894
Pravda Ricardo SVP & Chief HR Officer 08/27/2021 90,742
Maselli Alessandro President & COO 08/27/2021 490,824
Gunther Scott SVP, Quality & Reg. Affairs 08/27/2021 545,725
Grippo Michael J SVP, Strategy & Corp. Dev. 08/27/2021 222,661
Gennadios Aristippos President Softgel & Oral Tech 08/27/2021 296,619
Fasman Steven L SVP & General Counsel 08/27/2021 801,344
Chiminski John R Chair & CEO 08/27/2021 5,830,710
Arnold Jonathan Pres. Oral & Specialty Deliv. 08/27/2021 59,271
Grippo Michael J SVP, Strategy & Corp. Dev. 01/13/2020 97,440
Grippo Michael J SVP, Strategy & Corp. Dev. 12/20/2019 134,736
Grippo Michael J SVP, Strategy & Corp. Dev. 12/19/2019 99,684
Castellano Thomas P SVP, Chief Financial Officer 07/26/2021 62,743
Schmidt Kay A SVP, Technical Operations 07/26/2021 61,838
Hopson Ricky VP, Chief Accounting Officer 07/26/2021 40,698
Pravda Ricardo SVP & Chief HR Officer 07/26/2021 51,777
Maselli Alessandro President & COO 07/26/2021 112,259
Gunther Scott SVP, Quality & Reg. Affairs 07/26/2021 121,967
Grippo Michael J SVP, Strategy & Corp. Dev. 07/26/2021 50,986
Gennadios Aristippos President Softgel & Oral Tech 07/26/2021 52,568
Fasman Steven L SVP & General Counsel 07/26/2021 175,114
Chiminski John R Chair & CEO 07/26/2021 1,259,038
Arnold Jonathan Pres. Oral & Specialty Deliv. 07/26/2021 13,566
Fasman Steven L SVP & General Counsel 07/15/2021 494,353
Pravda Ricardo SVP & Chief HR Officer 06/23/2021 309,624
Schmidt Kay A SVP, Technical Operations 03/22/2021 148,078
Fasman Steven L SVP & General Counsel 03/18/2021 839,445
Fasman Steven L SVP & General Counsel 03/18/2021 2,262,770
Chiminski John R Chair & CEO 03/18/2021 1,520,764
Chiminski John R Chair & CEO 03/19/2021 7,698,674
Chiminski John R Chair & CEO 03/18/2021 4,439,855
Chiminski John R Chair & CEO 03/19/2021 19,402,784
Joseph Wetteny SVP & Chief Financial Officer 02/16/2021 262,799
Joseph Wetteny SVP & Chief Financial Officer 02/16/2021 622,685
Joseph Wetteny SVP & Chief Financial Officer 02/08/2021 523,613
Whitlow Ricci S President, CSS 01/21/2021 82,244
Flynn Karen Pres. Biologics & CCO 01/11/2021 278,279
Gunther Scott SVP, Quality & Reg. Affairs 01/06/2021 6,392
Whitlow Ricci S President, CSS 01/04/2021 8,667
Schmidt Kay A SVP, Technical Operations 01/04/2021 7,623
Pravda Ricardo SVP & Chief HR Officer 01/04/2021 8,145
Maselli Alessandro President & COO 01/04/2021 15,454
Joseph Wetteny SVP & Chief Financial Officer 01/04/2021 17,960
Gunther Scott SVP, Quality & Reg. Affairs 01/04/2021 12,530
Grippo Michael J SVP, Strategy & Corp. Dev. 01/04/2021 13,157
Gennadios Aristippos President Softgel & Oral Tech 01/04/2021 11,486
Flynn Karen Pres. Biologics & CCO 01/04/2021 10,338
Fasman Steven L SVP & General Counsel 01/04/2021 19,735
Arnold Jonathan Pres. Oral & Specialty Deliv. 01/04/2021 1,671
Gennadios Aristippos President Softgel & Oral Tech 12/21/2020 446,526
Gennadios Aristippos President Softgel & Oral Tech 12/21/2020 1,405,044
Zippelius Peter Director 11/23/2020 267,138,411
Zippelius Peter Director 11/23/2020 535,237,724
Fasman Steven L SVP & General Counsel 11/11/2020 244,901
Schmidt Kay A SVP, Technical Operations 10/23/2020 39,958
Schmidt Kay A SVP, Technical Operations 10/14/2020 278,045
Fasman Steven L SVP & General Counsel 10/14/2020 885,883
Fasman Steven L SVP & General Counsel 10/14/2020 393,426
Fasman Steven L SVP & General Counsel 10/14/2020 512,934
Grippo Michael J SVP, Strategy & Corp. Dev. 10/12/2020 159,583
Arnold Jonathan Pres. Oral & Specialty Deliv. 10/07/2020 2,142,381
Arnold Jonathan Pres. Oral & Specialty Deliv. 10/07/2020 1,213,364
Arnold Jonathan Pres. Oral & Specialty Deliv. 10/07/2020 1,457,412
Arnold Jonathan Pres. Oral & Specialty Deliv. 10/04/2020 20,611
Gunther Scott SVP, Quality & Reg. Affairs 10/02/2020 441,688
Gunther Scott SVP, Quality & Reg. Affairs 10/02/2020 264,639
Gunther Scott SVP, Quality & Reg. Affairs 10/02/2020 372,608
Chiminski John R Chair & CEO 10/02/2020 7,418,449
Chiminski John R Chair & CEO 10/02/2020 4,130,817
Chiminski John R Chair & CEO 10/02/2020 15,673,809
Grippo Michael J SVP, Strategy & Corp. Dev. 09/02/2020 201,378
Schmidt Kay A SVP, Technical Operations 08/27/2020 79,290
Pravda Ricardo SVP & Chief HR Officer 08/27/2020 82,711
Maselli Alessandro President & COO 08/27/2020 369,873
Joseph Wetteny SVP & Chief Financial Officer 08/27/2020 305,231
Gunther Scott SVP, Quality & Reg. Affairs 08/27/2020 247,605
Grippo Michael J SVP, Strategy & Corp. Dev. 08/27/2020 209,802
Gennadios Aristippos President Softgel & Oral Tech 08/27/2020 384,521
Fasman Steven L SVP & General Counsel 08/27/2020 585,552
Chiminski John R Chair & CEO 08/27/2020 5,172,960
Arnold Jonathan Pres. Oral & Specialty Deliv. 08/27/2020 265,147
Kreuzburg Christa Director 08/22/2020 82,252
Chiminski John R Chair & CEO 08/23/2020 402,092
LUCIER GREGORY T Director 07/30/2020 2,162,160
Schmidt Kay A SVP, Technical Operations 07/24/2020 41,147
Pravda Ricardo SVP & Chief HR Officer 07/24/2020 159,116
Maselli Alessandro President & COO 07/24/2020 76,742
Joseph Wetteny SVP & Chief Financial Officer 07/24/2020 62,128
Gunther Scott SVP, Quality & Reg. Affairs 07/24/2020 52,739
Grippo Michael J SVP, Strategy & Corp. Dev. 07/24/2020 43,432
Gennadios Aristippos President Softgel & Oral Tech 07/24/2020 80,334
Fasman Steven L SVP & General Counsel 07/24/2020 100,172
Chiminski John R Chair & CEO 07/24/2020 542,253
Arnold Jonathan Pres. Oral & Specialty Deliv. 07/24/2020 309,905
Gunther Scott SVP, Quality & Reg. Affairs 06/29/2020 203,318
Gennadios Aristippos President Softgel & Oral Tech 06/25/2020 1,016,890
Gennadios Aristippos President Softgel & Oral Tech 06/25/2020 622,541
Gennadios Aristippos President Softgel & Oral Tech 06/25/2020 607,725
CARROLL J MARTIN Director 05/12/2020 260,244
CARROLL J MARTIN Director 05/12/2020 260,244
Whitlow Ricci S President, CSS 04/09/2020 13,550
Schmidt Kay A SVP, Technical Operations 04/09/2020 12,760
Pravda Ricardo SVP & Chief HR Officer 04/09/2020 12,760
Maselli Alessandro President & COO 04/09/2020 17,785
Joseph Wetteny SVP & Chief Financial Officer 04/09/2020 19,705
Gunther Scott SVP, Quality & Reg. Affairs 04/09/2020 13,720
Grippo Michael J SVP, Strategy & Corp. Dev. 04/09/2020 14,454
Gennadios Aristippos President Softgel & Oral Tech 04/09/2020 15,752
Flynn Karen Pres. Biologics & CCO 04/09/2020 20,269
Fasman Steven L SVP & General Counsel 04/09/2020 21,794
BUZY PETER L President, Gene Therapy 04/09/2020 15,018
Arnold Jonathan Pres. Oral & Specialty Deliv. 04/09/2020 14,905
LUCIER GREGORY T Director 02/13/2020 119,420
Schmidt Kay A SVP, Technical Operations 02/02/2020 12,648
Maselli Alessandro President & COO 12/16/2019 386,512
Pravda Ricardo SVP & Chief HR Officer 11/26/2019 137,718
Gennadios Aristippos President Softgel & Oral Tech 11/25/2019 4,131,218
Gennadios Aristippos President Softgel & Oral Tech 11/25/2019 2,272,760
Gennadios Aristippos President Softgel & Oral Tech 11/25/2019 2,378,203
Grippo Michael J SVP, Strategy & Corp. Dev. 11/22/2019 19,552
Chiminski John R Chair & CEO 10/07/2019 1,664,907
Chiminski John R Chair & CEO 10/07/2019 1,160,409
Chiminski John R Chair & CEO 10/07/2019 4,739,580
LUCIER GREGORY T Director 09/09/2019 103,280
Maselli Alessandro President & COO 09/09/2019 173,132
Schmidt Kay A SVP, Technical Operations 08/22/2019 63,692
Pravda Ricardo SVP, Human Resources 08/22/2019 67,282
Maselli Alessandro President & COO 08/22/2019 301,942
Littlejohns Barry President, Biologics & SDD 08/22/2019 396,513
Kreuzburg Christa Director 08/23/2019 66,703
Joseph Wetteny SVP & Chief Financial Officer 08/22/2019 230,682
HEGWOOD PAUL W JR President, CSS 08/22/2019 59,052
Gunther Scott SVP, Quality & Reg. Affairs 08/22/2019 72,751
Gennadios Aristippos President, Softgel Tech. 08/22/2019 210,188
Fasman Steven L SVP & General Counsel 08/22/2019 492,796
Chiminski John R Chair & CEO 08/22/2019 2,859,609
Arnold Jonathan President, Oral Drug Delivery 08/22/2019 152,739
Schmidt Kay A SVP, Technical Operations 07/26/2019 61,784
Pravda Ricardo SVP, Human Resources 07/26/2019 85,775
Maselli Alessandro President & COO 07/26/2019 56,344
Littlejohns Barry President, Biologics & SDD 07/26/2019 70,659
Joseph Wetteny SVP & Chief Financial Officer 07/26/2019 54,626
HEGWOOD PAUL W JR President, CSS 07/26/2019 75,469
Gunther Scott SVP, Quality & Reg. Affairs 07/26/2019 93,105
Gennadios Aristippos President, Softgel Tech. 07/26/2019 42,830
Fasman Steven L SVP & General Counsel 07/26/2019 126,258
Chiminski John R Chair & CEO 07/26/2019 763,448
Arnold Jonathan President, Oral Drug Delivery 07/26/2019 137,080
CARROLL J MARTIN Director 07/15/2019 262,313
CARROLL J MARTIN Director 07/15/2019 262,313
Littlejohns Barry President, Biologics & SDD 07/12/2019 1,781,383
Littlejohns Barry President, Biologics & SDD 07/12/2019 952,938
Littlejohns Barry President, Biologics & SDD 07/12/2019 853,344
Fasman Steven L SVP & General Counsel 07/11/2019 1,028,350
Fasman Steven L SVP & General Counsel 07/11/2019 741,142
Fasman Steven L SVP & General Counsel 07/11/2019 219,024
BUZY PETER L President, Gene Therapy 05/29/2019 2,008,285
Joseph Wetteny SVP & Chief Financial Officer 05/28/2019 216,218
Joseph Wetteny SVP & Chief Financial Officer 05/28/2019 101,242
MOREL DONALD E JR Director 05/15/2019 444,400
LUCIER GREGORY T Director 05/09/2019 90,160
Gennadios Aristippos President, Softgel Tech. 03/21/2019 284,385
Gennadios Aristippos President, Softgel Tech. 03/21/2019 144,885
Gennadios Aristippos President, Softgel Tech. 03/21/2019 143,089
Miyamoto Lance SVP, Human Resources 03/07/2019 3,410,816
Miyamoto Lance SVP, Human Resources 03/07/2019 1,896,336
Miyamoto Lance SVP, Human Resources 03/07/2019 1,853,379
Kreuzburg Christa Director 02/16/2019 15,047
Downie William SVP, Global Sales & Marketing 02/15/2019 408,912
Downie William SVP, Global Sales & Marketing 02/15/2019 307,505
Downie William SVP, Global Sales & Marketing 02/15/2019 307,230
Fasman Steven L SVP & General Counsel 01/28/2019 189,712
GREISCH JOHN J Director 11/08/2018 488,930
Miyamoto Lance SVP, Human Resources 10/16/2018 487,688
Miyamoto Lance SVP, Human Resources 10/16/2018 218,520
Miyamoto Lance SVP, Human Resources 10/16/2018 277,313
Littlejohns Barry President, Biologics & SDD 10/15/2018 4,061,815
Littlejohns Barry President, Biologics & SDD 10/15/2018 2,151,891
Littlejohns Barry President, Biologics & SDD 10/15/2018 1,968,115
Joseph Wetteny SVP & Chief Financial Officer 10/15/2018 12,565
Chiminski John R Chair, President & CEO 10/01/2018 9,046,234
Chiminski John R Chair, President & CEO 10/01/2018 6,027,735
Chiminski John R Chair, President & CEO 10/01/2018 5,916,299
MOREL DONALD E JR Director 09/13/2018 430,000
Miyamoto Lance SVP, Human Resources 08/27/2018 43,092
Maselli Alessandro SVP, Global Operations 08/27/2018 18,643
Littlejohns Barry President, Biologics & SDD 08/27/2018 41,215
Joseph Wetteny SVP & Chief Financial Officer 08/27/2018 21,917
HEGWOOD PAUL W JR President, CSS 08/27/2018 22,048
Gunther Scott SVP, Quality & Reg. Affairs 08/27/2018 25,759
Fasman Steven L SVP & General Counsel 08/27/2018 46,411
Downie William SVP, Global Sales & Marketing 08/27/2018 56,365
Chiminski John R Chair, President & CEO 08/27/2018 427,126
Arnold Jonathan President, Oral Drug Delivery 08/27/2018 22,616
Miyamoto Lance SVP, Human Resources 08/27/2018 43,092
Maselli Alessandro SVP, Global Operations 08/27/2018 18,643
Littlejohns Barry President, Biologics & SDD 08/27/2018 41,215
Joseph Wetteny SVP & Chief Financial Officer 08/27/2018 21,917
HEGWOOD PAUL W JR President, CSS 08/27/2018 22,048
Gunther Scott SVP, Quality & Reg. Affairs 08/27/2018 25,759
Fasman Steven L SVP & General Counsel 08/27/2018 46,411
Downie William SVP, Global Sales & Marketing 08/27/2018 56,365
Chiminski John R Chair, President & CEO 08/27/2018 427,126
Arnold Jonathan President, Oral Drug Delivery 08/27/2018 22,616
Miyamoto Lance SVP, Human Resources 08/23/2018 89,056
Maselli Alessandro SVP, Global Operations 08/23/2018 15,435
Littlejohns Barry President, Biologics & SDD 08/23/2018 85,208
Joseph Wetteny SVP & Chief Financial Officer 08/23/2018 76,758
HEGWOOD PAUL W JR President, CSS 08/23/2018 18,196
Gunther Scott SVP, Quality & Reg. Affairs 08/23/2018 21,375
Fasman Steven L SVP & General Counsel 08/23/2018 96,000
Downie William SVP, Global Sales & Marketing 08/23/2018 116,580
Chiminski John R Chair, President & CEO 08/23/2018 734,577
Arnold Jonathan President, Oral Drug Delivery 08/23/2018 46,724
Fasman Steven L SVP & General Counsel 06/20/2018 457,658
Fasman Steven L SVP & General Counsel 06/20/2018 375,011
Fasman Steven L SVP & General Counsel 06/20/2018 94,089
Downie William SVP, Global Sales & Marketing 03/08/2018 530,917
Downie William SVP, Global Sales & Marketing 03/08/2018 405,239
Downie William SVP, Global Sales & Marketing 03/08/2018 379,628
Chiminski John R Chair, President & CEO 12/11/2017 4,971,512
Chiminski John R Chair, President & CEO 12/11/2017 2,213,596
Chiminski John R Chair, President & CEO 12/12/2017 3,089,287
Chiminski John R Chair, President & CEO 12/11/2017 4,099,740
Roehrhoff Uwe Director 11/21/2017 294,150
Fasman Steven L SVP & General Counsel 10/23/2017 68,469
Chiminski John R Chair, President & CEO 10/23/2017 154,035
Chiminski John R Chair, President & CEO 09/16/2017 870,320
Miyamoto Lance SVP - Human Resources 08/29/2017 892,131
Miyamoto Lance SVP - Human Resources 08/29/2017 475,135
Miyamoto Lance SVP - Human Resources 08/29/2017 325,329
Dolan Christine SVP - Product Development 08/29/2017 231,105
Dolan Christine SVP - Product Development 08/29/2017 169,915
Dolan Christine SVP - Product Development 08/29/2017 61,768
WALSH MATTHEW M EVP & Chief Financial Officer 08/24/2017 290,306
Miyamoto Lance SVP - Human Resources 08/24/2017 126,897
Maselli Alessandro SVP - Global Operations 08/24/2017 25,281
Littlejohns Barry President - DDS 08/24/2017 119,714
Joseph Wetteny President - CSS 08/24/2017 64,153
Gunther Scott SVP, Quality & Reg. Affairs 08/24/2017 30,597
Gennadios Aristippos See Remarks 08/24/2017 92,708
Fasman Steven L See Remarks 08/24/2017 134,784
Downie William SVP, Global Sales & Marketing 08/24/2017 198,725
Dolan Christine SVP - Product Development 08/24/2017 66,230
Chiminski John R President & CEO 08/24/2017 685,609
Dolan Christine SVP - Product Development 08/01/2017 25,963
WALSH MATTHEW M EVP & Chief Financial Officer 07/31/2017 112,953
Miyamoto Lance SVP - Human Resources 07/31/2017 49,378
Maselli Alessandro SVP - Global Operations 07/31/2017 24,584
Littlejohns Barry President - DDS 07/31/2017 46,580
Joseph Wetteny President - CSS 07/31/2017 24,899
Gunther Scott SVP, Quality & Reg. Affairs 07/31/2017 29,550
Downie William SVP, Global Sales & Marketing 07/31/2017 77,319
Dolan Christine SVP - Product Development 07/31/2017 25,668
Chiminski John R President & CEO 07/31/2017 133,446
WALSH MATTHEW M See Remarks 06/08/2017 1,735,814
WALSH MATTHEW M See Remarks 06/08/2017 884,064
Johnson Sharon See Remarks 04/25/2017 1,519,368
Johnson Sharon See Remarks 04/25/2017 1,047,668
Johnson Sharon See Remarks 04/25/2017 265,640
Downie William See Remarks 03/20/2017 1,190,398
Downie William See Remarks 03/20/2017 770,994
Downie William See Remarks 03/20/2017 236,293
Chiminski John R See Remarks 03/16/2017 3,786,653
Chiminski John R See Remarks 03/16/2017 2,213,586
Chiminski John R See Remarks 03/16/2017 2,106,756
Chiminski John R See Remarks 03/20/2017 5,781
MOREL DONALD E JR Director 02/15/2017 292,700
Blackstone Management Associates V L.L.C. 10% Owner 09/09/2016 403,234,623
Blackstone Management Associates V L.L.C. 10% Owner 06/09/2016 215,333,563
WALSH MATTHEW M See Remarks 05/27/2016 1,959,694
WALSH MATTHEW M See Remarks 05/27/2016 1,398,010
WALSH MATTHEW M See Remarks 05/27/2016 611,533
CARROLL J MARTIN Director 09/04/2015 81,780
Chiminski John R See Remarks 08/17/2015 2,078,531
Chiminski John R See Remarks 08/17/2015 1,071,000
Chiminski John R See Remarks 08/19/2015 100,263
Chiminski John R See Remarks 08/17/2015 1,201,590
Chiminski John R See Remarks 08/03/2015 2,190,873
Chiminski John R See Remarks 08/03/2015 1,071,000
Chiminski John R See Remarks 08/03/2015 1,194,126
WALSH MATTHEW M See Remarks 07/27/2015 1,755,123
WALSH MATTHEW M See Remarks 07/27/2015 974,229
WALSH MATTHEW M See Remarks 07/27/2015 847,223
Chiminski John R See Remarks 07/20/2015 1,967,419
Chiminski John R See Remarks 07/20/2015 1,071,000
Chiminski John R See Remarks 07/20/2015 972,581
Chiminski John R See Remarks 07/06/2015 1,941,486
Chiminski John R See Remarks 07/06/2015 1,071,000
Chiminski John R See Remarks 07/06/2015 992,514
Blackstone Management Associates V L.L.C. 10% Owner 06/11/2015 51,898,808
Blackstone Management Associates V L.L.C. 10% Owner 06/08/2015 345,992,042
WALSH MATTHEW M See Remarks 04/06/2015 2,068,844
WALSH MATTHEW M See Remarks 04/06/2015 1,092,881
WALSH MATTHEW M See Remarks 04/06/2015 1,047,979
Houlton Scott See Remarks 04/01/2015 2,018,301
Houlton Scott See Remarks 04/01/2015 1,174,870
Houlton Scott See Remarks 04/01/2015 497,504
Gennadios Aristippos See Remarks 04/01/2015 1,220,145
Gennadios Aristippos See Remarks 04/01/2015 734,573
Gennadios Aristippos See Remarks 04/01/2015 761,209
WALSH MATTHEW M See Remarks 03/27/2015 332,274
Leonard Stephen See Remarks 03/27/2015 2,522,303
Leonard Stephen See Remarks 03/27/2015 1,456,560
Leonard Stephen See Remarks 03/27/2015 934,181
Johnson Sharon See Remarks 02/13/2015 926,739
Johnson Sharon See Remarks 02/17/2015 1,456,831
Johnson Sharon See Remarks 02/13/2015 529,074
Johnson Sharon See Remarks 02/17/2015 856,691
Johnson Sharon See Remarks 02/17/2015 676,314
Johnson Sharon See Remarks 02/13/2015 447,962
Kurt Nielsen See Remarks 02/17/2015 1,162,979
Kurt Nielsen See Remarks 02/17/2015 765,979
Kurt Nielsen See Remarks 02/17/2015 797,384
Kurt Nielsen See Remarks 02/17/2015 768,576
Kurt Nielsen See Remarks 02/17/2015 514,508
Kurt Nielsen See Remarks 02/17/2015 548,200
Houlton Scott See Remarks 02/13/2015 53,534
Houlton Scott See Remarks 02/17/2015 494
Houlton Scott See Remarks 02/13/2015 35,268
Houlton Scott See Remarks 02/17/2015 334,259
Houlton Scott See Remarks 02/17/2015 360,244
Houlton Scott See Remarks 02/13/2015 39,592
Leonard Stephen See Remarks 02/13/2015 42,737
Leonard Stephen See Remarks 02/13/2015 26,861
Leonard Stephen See Remarks 02/13/2015 28,340
Downie William See Remarks 02/13/2015 142,699
Downie William See Remarks 02/17/2015 2,614,218
Downie William See Remarks 02/17/2015 1,488,358
Downie William See Remarks 02/13/2015 66,423
Downie William See Remarks 02/13/2015 30,089
Downie William See Remarks 02/17/2015 1,251,900
WALSH MATTHEW M See Remarks 02/13/2015 89,952
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
1.18%
1Q
09/30/2021
03/31/2021
1.47%
2Q
09/30/2021
09/30/2020
3.29%
4Q
09/30/2021
06/30/2020
12.92%
5Q
09/30/2021
03/31/2020
15.06%
6Q
09/30/2021
12/31/2019
16.40%
7Q
09/30/2021
09/30/2019
18.08%
8Q
09/30/2021
06/30/2019
17.84%
9Q
09/30/2021
03/31/2019
18.14%
10Q
09/30/2021
12/31/2018
18.57%
11Q
09/30/2021
09/30/2018
21.00%
12Q
09/30/2021
06/30/2018
29.13%
13Q
09/30/2021
03/31/2018
29.75%
14Q
09/30/2021
12/31/2017
33.00%
15Q
09/30/2021
09/30/2017
34.60%
16Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
1.18%
1Q
03/31/2021
1.47%
2Q
09/30/2020
3.29%
4Q
06/30/2020
12.92%
5Q
03/31/2020
15.06%
6Q
12/31/2019
16.40%
7Q
09/30/2019
18.08%
8Q
06/30/2019
17.84%
9Q
03/31/2019
18.14%
10Q
12/31/2018
18.57%
11Q
09/30/2018
21.00%
12Q
06/30/2018
29.13%
13Q
03/31/2018
29.75%
14Q
12/31/2017
33.00%
15Q
09/30/2017
34.60%
16Q
Load More